Nature Biotechnology23, 1189 - 1190 (2005)
Published online: 30 September 2005; | doi:10.1038/nbt1005-1189
There is an Erratum (February 2006) associated with this News.
Korean biotechs seize opportunity to list on public markets
Sabine Louët
Seoul
Cash-starved biotech companies in Korea are hoping to capitalize on changes to the listing rules for the Korean stock market introduced earlier this year to go public
